- “Patients will be treated with targeted therapy cocktails based on their molecular profiles, rather than individual drugs at a one-at-a-time manner.”
- “More personalized medicines, at affordable costs to patients and the systems.”
- “Solid tumors treated with CAR T-cell therapy.”
- “New therapies to stop resistance to TKIs.”
- “More cancers with progression-free disease.”
- “Approval for sipuleucel-T (Provenge) for newly diagnosed patients with prostate cancer.”
- “Price decreases for standard lab testing.”
With these advancements also come new challenges educational opportunities for oncology nurses. New treatment methods will come with different adverse events to monitor, making nurse-patient communication even more important.
Additionally, as the healthcare system gets more complex with a nearly constant flow of new therapies, the role of the oncology nurse will continue to be critical in the evaluation, care, and maintenance treatment of cancer survivors.
Checkout OncNursingNews.com to stay abreast of the most recent practice-changing research in the field of oncology nursing. Subscribe to our emails to never miss a beat on weekly top stories and breaking news FDA approvals.